IRIS
CORTI, ANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.154
NA - Nord America 783
AS - Asia 782
AF - Africa 7
SA - Sud America 2
OC - Oceania 1
Totale 2.729
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 781
SE - Svezia 670
CN - Cina 394
SG - Singapore 336
RU - Federazione Russa 222
IT - Italia 92
FI - Finlandia 55
DE - Germania 53
IE - Irlanda 39
IN - India 34
NL - Olanda 8
EG - Egitto 7
GB - Regno Unito 7
HK - Hong Kong 5
IR - Iran 5
JP - Giappone 3
AE - Emirati Arabi Uniti 2
FR - Francia 2
RO - Romania 2
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
BR - Brasile 1
CA - Canada 1
CL - Cile 1
IQ - Iraq 1
JM - Giamaica 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 2.729
Salva come PNG Salva come JPEG
Città #
Lawrence 266
Princeton 266
Shanghai 235
Singapore 213
Helsinki 55
Moscow 53
Ashburn 46
Milan 42
Dublin 39
New York 32
Pune 32
Boardman 19
Dallas 18
Beijing 11
Guangzhou 11
Los Angeles 11
Seattle 9
Xi'an 8
Wuxi 7
Hangzhou 5
Jiaxing 5
Shenzhen 5
Washington 5
Alexandria 4
Borås 4
Rome 4
San Diego 4
Ancona 3
Brescia 3
Dongguan 3
London 3
Tanta 3
Abu Dhabi 2
Delhi 2
Foshan 2
Frankfurt am Main 2
Honolulu 2
Maropati 2
Naaldwijk 2
Nanjing 2
Naples 2
Palermo 2
Phoenix 2
Pisa 2
Qingdao 2
Teverola 2
Tokyo 2
Turin 2
Utrecht 2
Zanjan 2
Zhengzhou 2
Zhenjiang 2
Abingdon 1
Amsterdam 1
Arbil 1
Arnsberg 1
Baku 1
Bergen 1
Bologna 1
Bratislava 1
Brussels 1
Böblingen 1
Cangzhou 1
Changsha 1
Chiaravalle 1
Dongyang 1
Falconara Marittima 1
Falkenstein 1
Ferrara 1
Fort Worth 1
Genoa 1
Gunzenhausen 1
Handan 1
Hanover 1
Henderson 1
Hong Kong 1
Huzhou 1
Jiangmen 1
Karasawa 1
Kashan 1
Kish 1
Kortenhoef 1
Kunming 1
Mainz 1
Missaglia 1
Monterosso Calabro 1
Monza 1
Mountain View 1
Nanchang 1
Nanyang 1
Newcastle 1
Nuremberg 1
Osimo 1
Paris 1
Pindamonhangaba 1
Rockville 1
Sacramento 1
San Francisco 1
San Mateo 1
Santa Clara 1
Totale 1.512
Salva come PNG Salva come JPEG
Nome #
A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer 28
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma 27
A pilot phase I study combining peptide-based vaccination and NGR-hTNF vessel targeting therapy in metastatic melanoma 23
CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study 23
Altered Chromogranin A Circulating Levels in Meniere’s Disease 22
Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models 22
Hematopoietic stem-and progenitor-cell gene therapy for hurler syndrome 22
Chromogranin-A production and fragmentation in patients with Takayasu arteritis. 20
Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma 20
An innovative platform approach for the development of ex-vivo gene therapies for the treatment of lysosomal storage diseases with skeletal involvement 20
A simple and robust nanosystem for photoacoustic imaging of bladder cancer based on α5β1-targeted gold nanorods 19
Cytoskeleton mediates negative inotropism and lusitropism of chromogranin A-derived peptides (human vasostatin1-78 and rat CgA(1-64)) in the rat heart 19
Aminopeptidase N (CD13)-positive bone marrow-derived cells induce angiogenesis and tumor growth: A potential non-malignant immune cell target against cancer 19
Ways to improve tumor uptake and penetration of drugs into solid tumors 19
Breaching the blood–brain tumor barrier for tumor therapy 19
A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins 19
The elusive role of proton pump inhibitors in COVID-19: Can plasma Chromogranin A levels hold the key? 18
Isoaspartate-glycine-arginine: A new tumor vasculature-targeting motif 18
T cells redirected to a minor histocompatibility antigen instruct intratumoral TNFα expression and empower adoptive cell therapy for solid tumors 18
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: Final results of a phase 2 trial 18
Early diagnosis of bladder cancer by photoacoustic imaging of tumor-targeted gold nanorods 17
Chromogranin A plasma levels predict mortality in COVID-19 17
Anti-urokinase monoclonal antibody, matrix bearing it, test method, biochemical test kits which use it. 17
Plasma levels of vasostatin-1, a chromogranin A fragment, are associated with carotid artery maximum stenosis: A pilot study 17
Nanogold Functionalized With Lipoamide-isoDGR: A Simple, Robust and Versatile Nanosystem for αvβ3-Integrin Targeting 17
Commentary: Granins, Secretory Granule Biogenesis, and Transport 16
A receptor-antibody sandwich assay for teicoplanin. 16
Agents regulating vascular permeability 16
Adoptive immunotherapy by avidin-driven cytotoxic T lymphocyte-tumor bridging 16
Catestatin inhibits obesity-induced macrophage infiltration and inflammation in the liver and suppresses hepatic glucose production, leading to improved insulin sensitivity 16
A new chromogranin A-dependent angiogenic switch activated by thrombin 16
Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours 15
[Activation and role of the tumor necrosis factor-alpha in congestive heart failure]. FT Attivazione e ruolo del fattore di necrosi tumorale alfa nello scompenso cardiaco congestizio. 15
Immobilized oligopeptides 15
Process for identifying polynucleotide sequences and device suitable therefor 15
Anti-idiotype monoclonal antibody directed against anti-TNF antibodies 15
Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis 15
Won't you come on in? How to favor lymphocyte infiltration in tumors 15
A monoclonal antibody that recognizes the receptor binding region of human urokinase plasminogen activator. 15
Affinity enhancement of complementary peptide recognition 15
Quantification of Chromogranin A and Its Fragments in Biological Fluids 14
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome 14
Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas 14
The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells 14
Conversation galante: How the immune and the neuroendocrine systems talk to each other 14
Cromogranina A per uso come reagente in un metodo diagnostico o prognostico 14
Autocrine saturation of pro-urokinase receptors on human A431cells 14
Overexpression of the hereditary hemochromatosis protein, HFE, in HeLa cells induces and iron-deficient phenotype 14
Spatiotemporal regulation of tumor angiogenesis by circulating chromogranin a cleavage and neuropilin-1 engagement 14
Vascular targeting, chemotherapy and active immunotherapy: teaming up to attack cancer 13
Identification of differentially glycosylated forms of the soluble p75 tumor-necrosis-factor (TNF) receptor in human urine 13
Targeted drug delivery and penetration into solid tumors. 13
Vascular attack and immunotherapy: a 'two hits' approach to improve biological treatment of cancer 13
Tumor targeting with biotinylated tumor necrosis factor alpha: Structure-activity relationships and mechanism of action on avidin pretargeted tumor cells 13
Oxidative stress biomarkers and chromogranin A in uremic patients: Effects of dialytic treatment 13
Mode of interaction between a monoclonal antibody and human TNF alpha. 13
Pushing tumor cells towards a malignant phenotype: stimuli from the microenvironment, intercellular communications, and alternative roads 13
Oral direct thrombin inhibition: a double-edged sword? 13
Tumor necrosis factor in heart failure 13
Targeting macrophages sensitizes chronic lymphocytic leukemia to apoptosis and inhibits disease progression 13
Immunohistochemistry of HFE in the duodenum of C282Y homozygotes with antisera for recombinant HFE protein 13
Cytokine conjugates (IL-12 –peptide conjugates) 13
Solid-phase receptor assay for antibiotics of the vancomycin class. 13
Tumor Necrosis Factor: methods and protocols 13
Monoclonal antibodies against the TNF type-I receptor, process for their production and use thereofAnticorpi monoclonali anti-recettore di tipo 1 del TNF alfa, procedimento per la loro produzione e loro uso 13
Modified cytokines for therapeutic use 13
Circulating chromogranin A 13
Chromogranin A regulates vesicle storage and mitochondrial dynamics to influence insulin secretion 13
The chromogranin A1-373 fragment reveals how a single change in the protein sequence exerts strong cardioregulatory effects by engaging neuropilin-1 13
Nitric oxide synthase in CHF - Reply 12
Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy 12
Influence of vasostatins, the chromogranin A-derived peptides, on the working heart of the eel (Anguilla anguilla): negative inotropy and mechanism of action 12
Tumor-necrosis-factor soluble receptors in patients with various degrees of congestive-heart-failure 12
Tumor-necrosis-factor (TNF)-alpha quantification by ELISA and bioassay - effects of TNF-alpha-soluble TNF-receptor (p55) complex dissociation during assay incubations 12
Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A 12
STRUCTURAL BASIS FOR THE INTERATION OF ISODGR WITH RGD-BINDING SITE OF αvβ3 INTEGRIN 12
Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. sp. 12
NGR-Tagged Nano-Gold: a new CD13-selective carrier for cytokine delivery to tumors 12
Chromogranin A is preferentially cleaved into pro-angiogenic peptides in the bone marrow of multiple myeloma patients 12
Binding of the glycopeptide antibiotic teicoplanin to D-alanyl-D-alanine-agarose: the effect of micellar aggregates. 12
Functional expression of two soluble forms of the TNF-receptor type I in mammalian cells 12
Targeted delivery of TNF using NGR-TNF in combination with chemotherapy as an effective and tolerable strategy in a hepatocarcinoma patient 12
Fusion of cytokines and targeting peptides 12
Receptor-antibody sandwich assay. 12
Targeted delivery of IFN gamma to tumor vessels uncouples antitumor from counterregulatory mechanisms 12
Tumor necrosis factor-α as a master regulator of inflammation in Erdheim-Chester disease: rationale for the successful treatment of patients with infliximab 12
Vasostatins 12
Succinimide-Based Conjugates Improve IsoDGR Cyclopeptide Affinity to αvβ3 without Promoting Integrin Allosteric Activation 12
Physiological levels of chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activity 12
A stapled chromogranin A-derived peptide is a potent dual ligand for integrins αvβ6 and αvβ8 12
Structure-activity relationships of chromogranin A in cell adhesion - Identification of an adhesion site for fibroblasts and smooth muscle cells 11
Chromogranin A Restricts Drug Penetration and Limits the Ability of NGR-TNF to Enhance Chemotherapeutic Efficacy 11
How to improve exposure of tumor cells to drugs - Promoter drugs increase tumor uptake and penetration of effector drugs 11
A rapid method for monitoring DNA labelling reactions with haptens. 11
Tumor necrosis factor in congestive heart failure: A mechanism of disease for the new millennium? 11
Effect of chromogranin A-derived vasostatin-1 on laser-induced choroidal neovascularization in the mouse 11
Tumor cell targeting with antibody-avidin complexes and biotinylated tumor necrosis factor alpha 11
Liposome-Mediated Therapy of Neuroblastoma 11
The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. 11
Tumor pretargeting with avidin improves the therapeutic index of biotinylated tumor necrosis factor alpha in mouse models 11
Totale 1.477
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.907
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.907
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 0 0 1 3 1 0
2020/20215 0 0 0 1 0 0 4 0 0 0 0 0
2021/2022111 0 0 0 70 0 7 7 5 2 2 1 17
2022/20231.296 604 245 115 3 2 138 42 67 64 5 5 6
2023/2024417 5 8 62 36 26 88 24 33 0 18 37 80
2024/2025951 461 37 54 101 80 218 0 0 0 0 0 0
Totale 2.861